Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion
Status:
Unknown status
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, non-randomized clinical study on the impact of
intravitreally administered ranibizumab (Lucentis) treatment on vision-related functioning
and emotional well-being in subjects with central or branch retinal vein occlusion.